Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Rheumatology
Volume 2016, Article ID 9068061, 4 pages
http://dx.doi.org/10.1155/2016/9068061
Case Report

Repository Corticotropin Injection for Treatment of Idiopathic Inflammatory Myopathies

1Arthritis and Osteoporosis Center of Richmond, 9600 Patterson Avenue, Richmond, VA 23229, USA
2Department of Pediatrics, University of Virginia Children’s Hospital, Box 800386, Charlottesville, VA 22908, USA
3Dermatology Associates of Virginia, P.C., 10800 Midlothian Turnpike, Suite 309, Richmond, VA 23226, USA
4Division of Rheumatology and Clinical Immunology, University of Pittsburgh, BST S725, 3500 Terrace Street, Pittsburgh, PA 15217, USA

Received 22 April 2016; Accepted 18 July 2016

Academic Editor: Tsai-Ching Hsu

Copyright © 2016 Aarat Patel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. C. Dalakas, “Immunotherapy of myositis: issues, concerns and future prospects,” Nature Reviews Rheumatology, vol. 6, no. 3, pp. 129–137, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. I. Marie and L. Mouthon, “Therapy of polymyositis and dermatomyositis,” Autoimmunity Reviews, vol. 11, no. 1, pp. 6–13, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Bingham and P. Emery, “Resistant rheumatoid arthritis clinics—a necessary development?” Rheumatology, vol. 39, no. 1, pp. 2–5, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. I. C. Chikanza and D. L. Kozaci, “Corticosteroid resistance in rheumatoid arthritis: molecular and cellular perspectives,” Rheumatology, vol. 43, no. 11, pp. 1337–1345, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. H.P. Acthar (R) Gel [package insert]. Mallinckrodt ARD, Inc. Hazelwood, MO, http://www.acthar.com/pdf/Acthar-PI.pdf.
  6. A. Catania, S. Gatti, G. Colombo, and J. M. Lipton, “Targeting melanocortin receptors as a novel strategy to control inflammation,” Pharmacological Reviews, vol. 56, no. 1, pp. 1–29, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. J. J. An, Y. Rhee, H. K. Se et al., “Peripheral effect of α-melanocyte-stimulating hormone on fatty acid oxidation in skeletal muscle,” Journal of Biological Chemistry, vol. 282, no. 5, pp. 2862–2870, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Levine, “Treating refractory dermatomyositis or polymyositis with adrenocorticotropic hormone gel: a retrospective case series,” Drug Design, Development and Therapy, vol. 6, pp. 133–139, 2012. View at Publisher · View at Google Scholar
  9. University of Pittsburgh, Mallinckrodt, Acthar in treatment of refractory dermatomyositis and polymyositis, ClinicalTrials.gov, NCT01906372, National Library of Medicine (US), Bethesda, Md, USA, 2013, https://clinicaltrials.gov/ct2/show/NCT01906372.